Jump to content

Milacemide

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Taavi (talk | contribs) at 17:37, 18 June 2020 (→top: clean up, typo(s) fixed: similiarly → similarly). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Milacemide
Skeletal formula of milacemide
Names
IUPAC name
2-(Pentylamino)acetamide[1]
Identifiers
3D model (JSmol)
ChEMBL
ChemSpider
MeSH milacemide
UNII
  • InChI=1S/C7H16N2O/c1-2-3-4-5-9-6-7(8)10/h9H,2-6H2,1H3,(H2,8,10) checkY
    Key: GJNNXIYZWIZFRH-UHFFFAOYSA-N checkY
  • CCCCCNCC(N)=O
Properties
C7H16N2O
Molar mass 144.218 g·mol−1
log P 0.754
Related compounds
Related compounds
 Tricine
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).

Milacemide (INN)[2] is an MAO-B inhibitor and glycine prodrug.[3] It has been studied for its effects on human memory and as a potential treatment for the symptoms of Alzheimer's disease.[4] Early clinical trials did not show positive results however,[3] and the drug is now abandoned and now it is a nonprescription drug . While milacemide is non amino-acid,it acts similarly to glycine in the brain[5]

References

  1. ^ "milacemide - Compound Summary". PubChem Compound. USA: National Center for Biotechnology Information. 8 August 2005. Identifiers and Related Records. Retrieved 9 January 2012.
  2. ^ "International Nonproprietary Names for Pharmaceutical Substances. Supplement to WHO Chronicle, 1983, Vol. 37, No. 6 (December). Recommended International Nonproprietary Names (Rec. INN): List 23" (PDF). World Health Organization. p. 6. Retrieved 8 January 2016.
  3. ^ a b Dysken, MW; Mendels, J; LeWitt, P; Reisberg, B; Pomara, N; Wood, J; Skare, S; Fakouhi, JD; Herting, RL (May 1992). "Milacemide: a placebo-controlled study in senile dementia of the Alzheimer type". Journal of the American Geriatrics Society. 40 (5): 503–6. doi:10.1111/j.1532-5415.1992.tb02019.x. PMID 1634705.
  4. ^ Harris, Carol Turkington ; foreword by Joseph R. (2002). The encyclopedia of the brain and brain disorders (2nd ed.). New York, NY: Facts on File. ISBN 0-8160-4774-X.{{cite book}}: CS1 maint: multiple names: authors list (link)
  5. ^ by Theodore I Lidsky and Jay S Schneider Phd, Brain Candy (2001). Brain Candy. New York,United States Of America: Simon & Schuster. pp. https://www.simonandschuster.co.uk/books/Brain-Candy/Theodore-Lidsky/9780743218436.


Stub icon

This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Milacemide&oldid=963235202"